Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer Undergoing Radiation Therapy

NCT06391034 is registered in ClinicalTrials.gov with Robert Bok, MD, PhD as lead sponsor.

NCT NCT06391034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06391034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer Undergoing Radiation Therapy
Lead sponsor
Robert Bok, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
September 24, 2024
Completion date
October 31, 2032
Enrollment
161 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer